Target intelligence / Profile preview

ZFP3 divergent transcript (ZFP3-DT)

Target
ZFP3-DT
Molecular classification
Other (long noncoding RNA), lncRNA
01

Overview

ZFP3-DT (ZFP3 divergent transcript) is annotated as a long noncoding RNA (lncRNA) gene found at the ZFP3 locus. Available data in gene and genomic databases describe ZFP3-DT as a non-protein-coding transcript, but there is no experimentally confirmed biological function, involvement in disease, or validation as a drug target in current biomedical literature[3]. It is distinct from the protein-coding gene ZFP3 (zinc finger protein 3), which is primarily studied in plants and functions as a C2H2-type zinc finger transcription factor involved in the regulation of cell wall biosynthesis and root hair formation in *Arabidopsis thaliana*[1][2]. There is currently no evidence that ZFP3-DT functions as a receptor or any other direct therapeutic target, and its relevance in mammalian or human biology remains unclear[3]. Important contextual note: The main literature describing functional ZFP3 activity pertains to the transcription factor in *Arabidopsis thaliana*[1][2]. ZFP3-DT, as a "divergent transcript," refers to a noncoding RNA transcribed in the opposite direction to the protein-coding ZFP3 gene. No credible sources currently assign ZFP3-DT any canonical biological function, therapeutic relevance, or drug interactions[3]. If you are seeking information about the **plant transcription factor** ZFP3, that is a different entity—a C2H2-type zinc finger transcription factor controlling gene expression involved in plant development and is not a human/animal drug target[1][2]. If you meant the protein-coding ZFP3 or ZFP35 in mammals, clarification is needed, as ZFP3-DT is not equivalent to those targets and is not considered a canonical therapeutic target in standard biomedical usage.

Other names
ZFP3-DTZFP3 divergent transcript

Beyond the preview

Go deeper on ZFP3 divergent transcript (ZFP3-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZFP3 divergent transcript (ZFP3-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call